Benjamin Landman is a child psychiatrist. He is chief resident at the Excellence Center for Autism and Neurodevelopmental Disorders at the Robert Debré Hospital, in Paris, France. He has a major interest in the identification of biomarkers in autism. He is mainly involved in the project SoNeTAA (Social Neuroscience for Therapeutic Approaches in Autism) and combines human-human and human-machine interactions with electroencephalography recording to study social cognition from a situated and reciprocal standpoint. The project aims to bridge the gap between state-of-the-art social neuroscience methods and clinical practices. He is also co-founder of the www.debrechildpsychiatry.org website.
Benjamin Landman
Chief resident
Center of Excellence for Autism Spectrum Disorders and Neurodevelopmental Disorders
From this contributor
Coronavirus tool kit may aid families with autistic children during lockdown
To help families cope with the sudden loss of professional support during the pandemic, one team in France has created a set of resources and information.
Coronavirus tool kit may aid families with autistic children during lockdown
By
Richard Delorme, Benjamin Landman
21 April 2020 | 4 min read
Explore more from The Transmitter
Trading places: What happens when neuroscience turns into machine learning, and machine learning turns into neuroscience?
Neuroscience has become increasingly concerned with prediction, and machine learning with causal explanation, with each field adopting methods from the other. I asked eight experts to weigh in on what we stand to learn from this exchange.
Trading places: What happens when neuroscience turns into machine learning, and machine learning turns into neuroscience?
Neuroscience has become increasingly concerned with prediction, and machine learning with causal explanation, with each field adopting methods from the other. I asked eight experts to weigh in on what we stand to learn from this exchange.
By
Samuel Gershman
23 March 2026 | 22 min read
Exon-skipping approach boosts levels of key Rett syndrome protein
Deleting a small region of the MECP2 gene partially restored function in neurons derived from people with Rett-associated variants.
Exon-skipping approach boosts levels of key Rett syndrome protein
Deleting a small region of the MECP2 gene partially restored function in neurons derived from people with Rett-associated variants.
By
Giorgia Guglielmi
20 March 2026 | 5 min read
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
By
Katie Moisse
19 March 2026 | 6 min read